Botanical species · safety record

Ageratina riparia

The EFSA Compendium of Botanicals holds 1 adverse-effect record for Ageratina riparia. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Ageratina riparia (Regel) R.M. King & H.Rob.

0Constituent measurements

1Safety records

1Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Plant parts

Effect types

Target tissues

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Pulmonary and cardiac	Lung	Live plants	—	Horse (as animal)	Subchronic	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Gibson, J. A., O'Sullivan, B. M. Lung lesions in horses fed mist flower (Eupatorium riparium). Australian veterinary journal, 1984, vol. 61, no. 8, p. 271-None.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature